David Brankow

4.9k citations

24 papers · 3.0k indexed · 2 hit papers · h-index 19

Impact in

Cancer Research top 5%
- Carcinogens and Genotoxicity Assessment
Oncology top 5%
- HER2/EGFR in Cancer Research
- Cancer-related Molecular Pathways

Papers in

Immunology and Allergy 3
- Cell Adhesion Molecules Research 3
Cancer Research 4
- Carcinogens and Genotoxicity Assessment 2

Co-authors: Charles Heidelberger Catherine A. Reznikoff John S. Bertram Sukdeb Mondal Sylvia Hu Deniz Toksoz Francis H. Martin K A Smith
Journals: Carcinogenesis (3 papers)Journal of Biological Chemistry (3 papers)Science (2 papers)Blood (2 papers)Journal of Cellular Biochemistry (1 paper)
Partner nations: United States United Kingdom

In The Last Decade

David Brankow

24 papers receiving 2.8k citations

Hit Papers

align trajectories log scale

Establishment and characterization of a cloned line of C3H mouse embryo cells sensitive to postconfluence inhibition of division. 1973 · 1.0k citations

Peers

Countries citing papers authored by David Brankow

Since Specialization

Citations

This map shows the geographic impact of David Brankow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Brankow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Brankow more than expected).

Fields of papers citing papers by David Brankow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Brankow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Brankow. The network helps show where David Brankow may publish in the future.

Co-authorship network

The 25 scholars most cited alongside David Brankow, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David Brankow Line = papers co-authored together David Brankow links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	An Acyl-Ghrelin-Specific Neutralizing Antibody Inhibits the Acute Ghrelin-Mediated Orexigenic Effects in Mice Molecular Pharmacology ·Shu-Chen Lu, Jing Xu, Narumol Chinookoswong, Shuying Liu, Shirley Steavenson, Colin V. Gegg, David Brankow, Richard Lindberg, Murielle M. Véniant, Wei Gu	2009	46
2	Evaluation of hyperglycosylated erythropoiesis stimulating proteins developed using glycoengineering Cancer Research ·Steven Elliott, Kenneth H. Aoki, Balaji Agoram, David Brankow, Sameer Doshi, Graham Molineux	2006	1
3	IL-18-Binding Protein Protects Against Lipopolysaccharide- Induced Lethality and Prevents the Development of Fas/Fas Ligand-Mediated Models of Liver Disease in Mice The Journal of Immunology ·Raffaella Faggioni, Russell C. Cattley, Jane Guo, Silvia Flores, Heather Brown, Meiying Qi, Songmei Yin, David Hill, Sheila Scully, Ching Chen, David Brankow, Jeffrey Lewis, Claudia Baikalov, Harvey Yamane, Shi‐Yuan Meng, Frank Martin, Sylvia Hu, T. Boone, Giorgio Senaldi	2001	101
4	Characterization of a new human B7-related protein: B7RP-1 is the ligand to the co-stimulatory protein ICOS International Immunology ·Steven K. Yoshinaga, Ming Zhang, Jeanne Pistillo, Tom Horan, Sanjay D. Khare, Kent Miner, 魏巍, T. Boone, David Brankow, 손종문, John Delaney, Ho Jae Han, Julian Andres Martínez-Rincon, Tadahiko Kohno, Raffi Manoukian, John Whoriskey, Marco Coccia	2000	117
5	Human Keratinocyte Growth Factor Recombinantly Expressed in Chinese Hamster Ovary Cells: Isolation of Isoforms and Characterization of Post-Translational Modifications Protein Expression and Purification ·Elisabetta Zanatta, Eric Hsu, Viswanatham Katta, David Brankow, Julia Tseng, Sylvia Hu, Charles F. Morris, William C. Kenney, Hsieng S. Lu	1998	25
6	Regulation of Tie Receptor Expression on Human Endothelial Cells by Protein Kinase C-Mediated Release of Soluble Tie Blood ·R Yabkowitz, Susanne Meyer, Donna Yanagihara, David Brankow, Eban-Odi Luisa Nang, Gary Elliott, DOA Minarda, Barry Ratzkin	1997	3
7	Regulation of Tie Receptor Expression on Human Endothelial Cells by Protein Kinase C-Mediated Release of Soluble Tie Blood ·R Yabkowitz, Susanne Meyer, Donna Yanagihara, David Brankow, Eban-Odi Luisa Nang, Gary Elliott, DOA Minarda, Barry Ratzkin	1997	48
8	ErbB Receptor Activation, Cell Morphology Changes, and Apoptosis Induced by Anti-Her2 Monoclonal Antibodies Biochemical and Biophysical Research Communications ·Yoshiko Kita, Julia Tseng, Thomas P. Horan, Jie Wen, John S. Philo, David Chang, Barry Ratzkin, Robert E. Pacifici, David Brankow, Sylvia Hu, Yi Luo, Duanzhi Wen, Tsutomu Arakawa, Margery Nicolson	1996	33
9	Post-translational Processing of Membrane-associated neu Differentiation Factor Proisoforms Expressed in Mammalian Cells Journal of Biological Chemistry ·Hsieng S. Lu, Shinichi Hara, 牛翠, Michael D. Jones, Viswanatham Katta, Michael D Ruffatti, Aihua Zou, David Brankow, Anastasia Orkwiszewski, Sylvia Hu, Duanzhi Wen	1995	38
10	Binding of Neu Differentiation Factor with the Extracellular Domain of Her2 and Her3 Journal of Biological Chemistry ·Thomas P. Horan, Jie Wen, Tsutomu Arakawa, Naili Liu, David Brankow, Sylvia Hu, Barry Ratzkin, John S. Philo	1995	65
11	Biosynthetic Processing of neu Differentiation Factor Journal of Biological Chemistry ·Teresa L. Burgess, Sandra L. Ross, Yixin Qian, David Brankow, Sylvia Hu	1995	80
12	NDF/heregulin stimulates the phosphorylation of Her3/erbB3 FEBS Letters ·Yoshiko Kita, F. Géher, Yi Luo, Duanzhi Wen, David Brankow, Sylvia Hu, Kyoungil Yoon, Sally A. Prigent, William J. Gullick, Margery Nicolson	1994	62
13	Post-translational processing of membrane-associated recombinant human stem cell factor expressed in Chinese hamster ovary cells Archives of Biochemistry and Biophysics ·Hsieng S. Lu, Christi L. Clogston, Jette Wypych, Vann P. Parker, Terry D. Lee, K M Swiderek, Mariam Michelle, Huang Jianzuo, David Chang, David Brankow, Xiaodong Liu, Steven G. Ogden, Subhash B. Karkare, Sylvia Hu, Krisztina M. Zsebo, Keith Langley	1992	32
14	Support of human hematopoiesis in long-term bone marrow cultures by murine stromal cells selectively expressing the membrane-bound and secreted forms of the human homolog of the steel gene product, stem cell factor. Proceedings of the National Academy of Sciences ·Deniz Toksoz, KM Zsebo, K A Smith, Trần Thị Khánh Linh, David Brankow, Sidney V. Suggs, Francis H. Martin, Daniel Williams	1992	257
15	A reassessment of methylcholanthrene transformation in the C3H10T1/2 cell culture system Carcinogenesis ·Hiroaki Sugimoto, David Brankow, Harvey R. Herschman	1990	2
16	The tumor promoters 12-O-tetradecanoylphorbol-13-acetate and okadaic acid differ in toxicity, mitogenic activity and induction of gene expression Carcinogenesis ·Harvey R. Herschman, Robert W. Lim, David Brankow, Hirota Fujiki	1989	37
17	Colony size, cell density and nature of the tumor promoter are critical variables in expression of a transformed phenotype (focus formation) in co-cultures of UV-TDTx and C3H10T1/2 cells Carcinogenesis ·Harvey R. Herschman, David Brankow	1987	14
18	Ultraviolet Irradiation Transforms C3H10T1/2 Cells to a Unique, Suppressible Phenotype Science ·Harvey R. Herschman, David Brankow	1986	21
19	Effects of promoters on DNA synthesis in C3H/10T1/2 mouse fibroblasts. PubMed ·A.R. Peterson, Владимир Бузан, David Brankow, Mharco Angelo Vista, Charles Heidelberger	1977	47
20	Establishment and characterization of a cloned line of C3H mouse embryo cells sensitive to postconfluence inhibition of division. PubMed ·Catherine A. Reznikoff, David Brankow, Charles Heidelberger Hit paper breakdown →	1973	1002

About David Brankow

David Brankow is a scholar working on Immunology and Allergy, Cancer Research, Oncology, Molecular Biology and Hematology, having authored 24 papers that have together received 3.0k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Virus-based gene therapy research (3 papers), Cell Adhesion Molecules Research (3 papers), Glycosylation and Glycoproteins Research (2 papers), Chemical Synthesis and Analysis (2 papers), Fibroblast Growth Factor Research (2 papers) and Carcinogens and Genotoxicity Assessment (2 papers). The work is most often cited by research in Cancer Research (645 citations), Oncology (659 citations), Molecular Biology (1.6k citations), Immunology (425 citations) and Immunology and Allergy (114 citations). David Brankow has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Charles Heidelberger, Catherine A. Reznikoff, John S. Bertram, Sukdeb Mondal, Sylvia Hu, Deniz Toksoz, Francis H. Martin, K A Smith, Daniel Williams and Sidney V. Suggs. Their work appears in journals such as Carcinogenesis, Journal of Biological Chemistry, Science, Blood and Journal of Cellular Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact